Recently, we downgraded AmSurg Corporation (NASDAQ:AMSG) to Underperform with a target price of $23.00. Although AmSurg recorded an 11% year-over-year growth in revenues during the fourth quarter of 2010, the company is witnessing several challenges in the near term, which gets reflected in its outlook for 2011. The company’s guidance of $740−$770 million in revenues [...]